Management of AIDS-Defining Cancers

  • Authors: David Aboulafia, MD (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 4/9/18 (What's New)

Summary

  • HIV-infected patients are at an increased risk of several cancers including AIDS-defining malignancies, KS, high-grade B-cell NHL, and ICC
  • Early referral to a multidisciplinary team that includes oncologists, infectious disease specialists, and pharmacists is recommended to optimize patient outcomes (Management Guidelines)[BHIVA HIV Cancer; Brook 2004]
  • Patients may present with minimal or rapidly progressing KS disease

    Action required

    Keywords: Cancer, Primary Care Considerations

    ©2018 Clinical Care Options, LLC. All Rights Reserved.

    The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.